Energetic characterization of the basic fibroblast growth factor-heparin interaction: identification of the heparin binding domain.

Fibroblast growth factors (FGF's) interact on cell surfaces with "low-affinity" heparan sulfate proteoglycans (HSPG) and "high-affinity" FGF receptors (FGFR) to initiate cell proliferation. Previous reports have implicated the binding of heparin, or heparan sulfate, to FGF as essential for FGF-mediated signal transduction and mitogenicity. However, the molecular recognition events which dictate the specificity of this interaction have remained elusive. Amino acid residues on the surface of basic FGF (bFGF) were targeted as potential heparin contacts on the basis of the position of sulfate anions in the X-ray crystal structure of bFGF and of a modeled pentasaccharide heparin-bFGF complex. Each identified amino acid was replaced individually with alanine by site-directed mutagenesis, and the resulting mutant proteins were characterized for differences in binding to a low molecular weight heparin (approximately 3000) by isothermal titrating calorimetry and also for differences in [NaCl] elution from a heparin-Sepharose affinity resin. The combination of site-directed mutagenesis and titrating calorimetry permitted an analysis of the energetic contributions of individual bFGF residues in the binding of heparin to bFGF. The key amino acids which comprise the heparin binding domain on bFGF constitute a discontinuous binding epitope and include K26, N27, R81, K119, R120, T121, Q123, K125, K129, Q134, and K135. Addition of the observed delta delta G degrees of binding for each single site mutant accounts for 8.56 kcal/mol (> 95%) of the free energy of binding. The delta delta G degrees values for N27A, R120A, K125A, and Q134A are all greater than 1 kcal/mol each, and these four amino acids together contribute 4.8 kcal/mol (56%) to the total binding free energy. Amino acid residues K119 through K135 reside in the C-terminal domain of bFGF and collectively contribute 6.6 kcal/mol (76%) of the binding free energy. Although 7 out of the 11 identified amino acids in the heparin binding domain are positively charged, a 7-fold increase in [NaCl] decreases the affinity of wild-type bFGF binding to heparin only 37-fold (Kd at 0.1 M NaCl = 470 nM vs Kd at 0.7 M NaCl = 17.2 microM). This indicates that pure electrostatic interactions contribute only 30% of the binding free energy as analyzed by polyelectrolyte theory and that more specific nonionic interactions, such as hydrogen bonding and van der Waals packing, contribute the majority of the free energy for this binding reaction.

[1]  D C Rees,et al.  Structural studies of the binding of the anti-ulcer drug sucrose octasulfate to acidic fibroblast growth factor. , 1993, Structure.

[2]  R. Linhardt,et al.  Nature of the interaction of heparin with acidic fibroblast growth factor. , 1993, Biochemistry.

[3]  E. Nabel,et al.  Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo , 1993, Nature.

[4]  M. Emi,et al.  Binding of lipoprotein lipase to heparin. Identification of five critical residues in two distinct segments of the amino-terminal domain. , 1993, The Journal of biological chemistry.

[5]  J. Xu,et al.  An essential heparin-binding domain in the fibroblast growth factor receptor kinase. , 1993, Science.

[6]  L. Cousens,et al.  Preparation of affinity-fractionated, heparin-derived oligosaccharides and their effects on selected biological activities mediated by basic fibroblast growth factor. , 1993, The Journal of biological chemistry.

[7]  D. Berryman,et al.  Site-directed mutagenesis of a putative heparin binding domain of avian lipoprotein lipase. , 1993, The Journal of biological chemistry.

[8]  J. Turnbull,et al.  Heparan sulphate in the binding and activation of basic fibroblast growth factor. , 1992, Glycobiology.

[9]  E. Edelman,et al.  Kinetics of basic fibroblast growth factor binding to its receptor and heparan sulfate proteoglycan: a mechanism for cooperactivity. , 1992, Biochemistry.

[10]  B. Faller,et al.  Heparin-induced conformational change and activation of mucus proteinase inhibitor. , 1992, Biochemistry.

[11]  A. Isacchi,et al.  Structure-function relationship of basic fibroblast growth factor: site-directed mutagenesis of a putative heparin-binding and receptor-binding region. , 1992, Biochemical and biophysical research communications.

[12]  G. M. Fox,et al.  Binding of heparin to basic fibroblast growth factor induces a conformational change. , 1992, Archives of biochemistry and biophysics.

[13]  M. Ultsch,et al.  Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. , 1992, Science.

[14]  J G Flanagan,et al.  Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells , 1992, Molecular and cellular biology.

[15]  Y. Katsube,et al.  Crystal structure of basic fibroblast growth factor at 1.6 A resolution. , 1994, Journal of biochemistry.

[16]  A. Mason,et al.  Calorimetric studies of the binding of ferric ions to ovotransferrin and interactions between binding sites. , 1991, Biochemistry.

[17]  K. Clauser,et al.  Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. , 1991, Science.

[18]  M. Klagsbrun,et al.  A dual receptor system is required for basic fibroblast growth factor activity , 1991, Cell.

[19]  R. Langer,et al.  Inhibitors of Angiogenesis , 1991, Bio/Technology.

[20]  B. Olwin,et al.  Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation , 1991, Science.

[21]  W. Heath,et al.  Mutations in the heparin-binding domains of human basic fibroblast growth factor alter its biological activity. , 1991, Biochemistry.

[22]  M. Petitou,et al.  Chemical synthesis of glycosaminoglycans: new approaches to antithrombotic drugs. , 1991, Nature.

[23]  S. Sprang,et al.  Three-dimensional structure of human basic fibroblast growth factor, a structural homolog of interleukin 1 beta. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[24]  B. Matthews,et al.  Three-dimensional structure of human basic fibroblast growth factor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[25]  S. Olson,et al.  Predominant contribution of surface approximation to the mechanism of heparin acceleration of the antithrombin-thrombin reaction. Elucidation from salt concentration effects. , 1991, The Journal of biological chemistry.

[26]  P. Grootenhuis,et al.  Constructing a molecular model of the interaction between Antithrombin-III and a potent synthetic heparin Analogue. , 1991 .

[27]  Jeffrey D. Esko,et al.  Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor , 1991, Cell.

[28]  P. Barr,et al.  Molecular cloning of a human basic fibroblast growth factor receptor cDNA and expression of a biologically active extracellular domain in a baculovirus system. , 1991, Growth factors.

[29]  J. Fiddes,et al.  Cloning, recombinant expression, and characterization of basic fibroblast growth factor. , 1991, Methods in enzymology.

[30]  M. Jaye,et al.  Possible dissociation of the heparin-binding and mitogenic activities of heparin-binding (acidic fibroblast) growth factor-1 from its receptor-binding activities by site-directed mutagenesis of a single lysine residue , 1990, The Journal of cell biology.

[31]  D. Rifkin,et al.  Heparin and heparan sulfate increase the radius of diffusion and action of basic fibroblast growth factor , 1990, The Journal of cell biology.

[32]  F. Richards,et al.  Thermodynamics of protein-peptide interactions in the ribonuclease S system studied by titration calorimetry. , 1990, Biochemistry.

[33]  M. Seno,et al.  Carboxyl-terminal structure of basic fibroblast growth factor significantly contributes to its affinity for heparin. , 1990, European journal of biochemistry.

[34]  J F Brandts,et al.  Rapid measurement of binding constants and heats of binding using a new titration calorimeter. , 1989, Analytical biochemistry.

[35]  M. Jalkanen,et al.  Molecular cloning of syndecan, an integral membrane proteoglycan , 1989, The Journal of cell biology.

[36]  R. Coffey,et al.  Growth of normal human keratinocytes and fibroblasts in serum‐free medium is stimulated by acidic and basic fibroblast growth factor , 1989, Journal of cellular physiology.

[37]  J. Folkman,et al.  Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules. , 1989, Biochemistry.

[38]  D. Rifkin,et al.  Interaction of heparin with human basic fibroblast growth factor: Protection of the angiogenic protein from proteolytic degradation by a glycosaminoglycan , 1989, Journal of cellular physiology.

[39]  T. Maciag,et al.  The heparin-binding (fibroblast) growth factor family of proteins. , 1989, Annual review of biochemistry.

[40]  D. Moscatelli Metabolism of receptor-bound and matrix-bound basic fibroblast growth factor by bovine capillary endothelial cells , 1988, The Journal of cell biology.

[41]  D. Rifkin,et al.  Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation , 1988, The Journal of cell biology.

[42]  A. Sommer,et al.  Recombinant basic fibroblast growth factor accelerates wound healing. , 1988, The Journal of surgical research.

[43]  M. L. Chiu,et al.  Stimulation of growth of keratinocytes by basic fibroblast growth factor. , 1988, The Journal of investigative dermatology.

[44]  R Guillemin,et al.  Receptor- and heparin-binding domains of basic fibroblast growth factor. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[45]  Harper Jw,et al.  Reductive methylation of lysine residues in acidic fibroblast growth factor: effect on mitogenic activity and heparin affinity , 1988 .

[46]  J. Folkman,et al.  Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[47]  D. Moscatelli,et al.  High and low affinity binding sites for basic fibroblast growth factor on cultured cells: Absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells , 1987, Journal of cellular physiology.

[48]  D. Gospodarowicz [9] Isolation and characterization of acidic and basic fibroblast growth factor , 1987 .

[49]  D. Gospodarowicz,et al.  Heparin protects basic and acidic FGF from inactivation , 1986, Journal of cellular physiology.

[50]  D. Gospodarowicz,et al.  The identification and partial characterization of the fibroblast growth factor receptor of baby hamster kidney cells. , 1985, The Journal of biological chemistry.

[51]  M. Klagsbrun,et al.  Accelerated wound repair, cell proliferation, and collagen accumulation are produced by a cartilage-derived growth factor , 1985, The Journal of cell biology.

[52]  M. Klagsbrun,et al.  Heparin affinity of anionic and cationic capillary endothelial cell growth factors: analysis of hypothalamus-derived growth factors and fibroblast growth factors. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[53]  D. Gospodarowicz,et al.  Isolation of brain fibroblast growth factor by heparin-Sepharose affinity chromatography: identity with pituitary fibroblast growth factor. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[54]  J. Folkman,et al.  Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor. , 1984, Science.

[55]  J. Kwak,et al.  Mg and Ca binding to heparin in the presence of added univalent salt , 1981 .

[56]  A. Grubb,et al.  Isolation and partial characterization of a low molecular weight trypsin inhibitor from human urine. , 1981, Biochimica et biophysica acta.

[57]  G. Phillips,et al.  The Relationship between Counterion Activity Coefficients and the Anticoagulant Activity of Heparin , 1978 .

[58]  T. Lohman,et al.  Thermodynamic analysis of ion effects on the binding and conformational equilibria of proteins and nucleic acids: the roles of ion association or release, screening, and ion effects on water activity , 1978, Quarterly Reviews of Biophysics.

[59]  G. S. Manning The molecular theory of polyelectrolyte solutions with applications to the electrostatic properties of polynucleotides , 1978, Quarterly Reviews of Biophysics.

[60]  T. Lohman,et al.  Ion effects on ligand-nucleic acid interactions. , 1976, Journal of molecular biology.